(J Am Heart Assoc. 2019;8:e012535 DOI: 10.1161/JAHA.119.012535.)31642357

Clinical PerspectiveWhat Is New?This large prospective population‐based study including more than 50 000 individuals used the Hospital Anxiety and Depression Scale depression score to examine a potential association between depressive symptoms and risk of abdominal aortic aneurysm.Our study shows that individuals with depressive symptoms have significantly higher risk of incident abdominal aortic aneurysms, after adjusting for established risk factors for the disease.What Are the Clinical Implications?Our study provides new support to consider assessment of symptoms of depression in the risk evaluation of development of abdominal aortic aneurysms.Assessing symptoms of depression in the risk evaluation of development of abdominal aortic aneurysms could be important when screening subgroups at increased risk of the disease.

Introduction {#jah34504-sec-0008}
============

Abdominal aortic aneurysm (AAA), a localized widening of the abdominal aorta, is a potentially life‐threatening disease occurring in 1% to 3% of the adult population.[1](#jah34504-bib-0001){ref-type="ref"}, [2](#jah34504-bib-0002){ref-type="ref"}, [3](#jah34504-bib-0003){ref-type="ref"} Untreated ruptured AAA is associated with almost 100% mortality. Smoking, age, heredity, and male sex have consistently been identified as risk factors for the disease, and strong associations have also been found with coronary artery disease, hypertension, and hyperlipidemia.[4](#jah34504-bib-0004){ref-type="ref"}, [5](#jah34504-bib-0005){ref-type="ref"}, [6](#jah34504-bib-0006){ref-type="ref"} Diabetes mellitus has been associated with a lower risk of AAA in some studies.[7](#jah34504-bib-0007){ref-type="ref"} The pathogenesis of AAA is not fully understood, and it is highly likely that unknown factors that have yet to be discovered may influence development of this disease.[8](#jah34504-bib-0008){ref-type="ref"}

Several studies have found that depression is associated with risk of cardiovascular disease (CVD).[9](#jah34504-bib-0009){ref-type="ref"}, [10](#jah34504-bib-0010){ref-type="ref"}, [11](#jah34504-bib-0011){ref-type="ref"}, [12](#jah34504-bib-0012){ref-type="ref"}, [13](#jah34504-bib-0013){ref-type="ref"}, [14](#jah34504-bib-0014){ref-type="ref"} A number of these studies have applied the Hospital Anxiety and Depression Scale (HADS)[15](#jah34504-bib-0015){ref-type="ref"} to measure symptoms of depression.[13](#jah34504-bib-0013){ref-type="ref"}, [14](#jah34504-bib-0014){ref-type="ref"} To our knowledge, only 1 previous study has reported a possible association between depression and development of AAA. This study showed a weak but increased risk of AAA in a subgroup with a history of depression.[12](#jah34504-bib-0012){ref-type="ref"}

The role of depression in development of CVD has often been attributed to a high prevalence of established cardiovascular risk factors, such as smoking, low physical activity, coronary heart disease, and diabetes mellitus, among individuals with depression.[9](#jah34504-bib-0009){ref-type="ref"} The amount of adjustments for cardiovascular risk factors has varied in previous studies.[9](#jah34504-bib-0009){ref-type="ref"}, [10](#jah34504-bib-0010){ref-type="ref"} However, functional biological changes that occur during depression may also affect the cardiovascular system.[16](#jah34504-bib-0016){ref-type="ref"}, [17](#jah34504-bib-0017){ref-type="ref"} Previous studies have shown that depression is associated with low‐grade chronic inflammation[17](#jah34504-bib-0017){ref-type="ref"} and elevated inflammatory markers.[16](#jah34504-bib-0016){ref-type="ref"}, [18](#jah34504-bib-0018){ref-type="ref"}, [19](#jah34504-bib-0019){ref-type="ref"}, [20](#jah34504-bib-0020){ref-type="ref"} Inflammation seems to be a crucial part of the pathophysiology behind development of AAA.[21](#jah34504-bib-0021){ref-type="ref"}, [22](#jah34504-bib-0022){ref-type="ref"}, [23](#jah34504-bib-0023){ref-type="ref"} Thus, there could also be a biological link between depression and AAA, mediated through inflammation.

The aim of the present study was to examine whether individuals with symptoms of depression have an increased risk of AAA. The results are based on a large population‐based prospective study from Norway.

Methods {#jah34504-sec-0009}
=======

Because of the sensitive nature of the data collected for this study from the HUNT study database, requests to access the data set from qualified researchers trained in human subject confidentiality protocols may be directed to the HUNT (Nord‐Trøndelag Health) study.[24](#jah34504-bib-0024){ref-type="ref"} The HUNT databank has precise information on all data exported to different projects and is able to reproduce these on request.

The HUNT Study {#jah34504-sec-0010}
--------------

The HUNT Study is a large multiphase population‐based health study conducted in the county of Nord‐Trøndelag in central Norway. The overall response rate was 89.4% in HUNT1 (1984--1986) (77 212 participants), 69.5% in HUNT2 (August 1995--1997) (65 237 participants), and 54.1% in HUNT3 (2006--2008) (50 807 participants).[25](#jah34504-bib-0025){ref-type="ref"} The population of Nord‐Trøndelag County (n=127 000 during HUNT2) is representative of the Norwegian population as a whole. The population has been found to be relatively stable (net out migration 0.3% per year) and homogeneous (\<3% nonwhite), which makes it suitable for epidemiological studies.[25](#jah34504-bib-0025){ref-type="ref"}, [26](#jah34504-bib-0026){ref-type="ref"}

Study Population {#jah34504-sec-0011}
----------------

The present study population includes 59 136 individuals who participated in HUNT2 and/or HUNT3 (53.8% participated in both), with no prior diagnosis of AAA, and who reached the age of 50 years before the study ended on December 31, 2014. Among the 59 136 individuals (52.4% women), 742 incident (27.1% women) AAAs were detected (1.2%). Median age at initial HUNT participation was 53.7 years (range 31.6--101.4 years). For each HUNT survey, participants completed questionnaires regarding clinical and demographic parameters and underwent clinical examination. The date of AAA diagnosis was obtained from hospital medical records. The unique personal identification number was used to link data on AAA diagnoses and death with exposure data from the HUNT study. In total, 622 cases of AAA (166 women) were identified among the 50 657 (51.2% women) individuals with complete data on all risk factors.

Follow‐Up Period {#jah34504-sec-0012}
----------------

The primary end point of this study was a diagnosis of AAA. Since only 3 cases of AAA were diagnosed before age 50 years, each individual was considered to be at risk of incident AAA from the age of 50 years, or from the date of initial HUNT participation at age \>50 years, until the date of diagnosis of AAA, time of death, or closing date of the study. Median age at start of follow‐up was 53.7 years (50--101.4 years), and median follow‐up time was 13 years (range 1 month--20 years). The Norwegian Cause of Death Registry was used to acquire information on dates of death. A total of 11 919 deaths were attributable to causes other than AAA (Figure [1](#jah34504-fig-0001){ref-type="fig"}). At the end of the study period the oldest person was 106 years old.

![Flow chart of the study population. AAA indicates abdominal aortic aneurysm; HUNT, Norwegian Nord‐Trøndelag Health Study.](JAH3-8-e012535-g001){#jah34504-fig-0001}

Diagnosis of AAA {#jah34504-sec-0013}
----------------

National screening for AAA is not implemented in Norway, and no ultrasound of the abdominal aorta was performed in HUNT. All patients diagnosed with AAA according to the *International Classification of Diseases, Ninth and Tenth Revisions* (*ICD‐9, ICD‐10* codes, 441.3--4 and I71.3--4) in the period 1995 through 2014 in Nord‐Trøndelag were identified. This information was obtained from hospital and outpatient registries from the 3 hospitals responsible for all outpatient care, follow‐up, and treatment of AAA in the region (St. Olavs Hospital, Levanger Hospital, and Namsos Hospital). All diagnoses were manually verified using patient charts. No distinction was made between symptomatic and asymptomatic AAA. From the total number of 742 AAAs, 134 ruptures (18%) were identified.

Assessment of Depressive Symptoms {#jah34504-sec-0014}
---------------------------------

A Norwegian version of the HADS questionnaire,[15](#jah34504-bib-0015){ref-type="ref"} a self‐reporting instrument used to measure severity of depressive symptoms, was included in HUNT2 and HUNT3, but not in HUNT1. This questionnaire can be used to assess symptoms of both anxiety (HADS‐A) and depression (HADS‐D) during the preceding week. It includes 7 questions on a Likert‐based scale of 0 to 3, with 2 separate ordinal subscales for anxiety and depression ranging from 0 to a maximum score of 21. A cut‐off point of ≥8 on the HADS‐D score has been shown to have a specificity of 0.79 and a sensitivity of 0.83 for clinical depression.[27](#jah34504-bib-0027){ref-type="ref"}, [28](#jah34504-bib-0028){ref-type="ref"} Accordingly, a HADS‐D score ≥8 was considered to reflect depressive symptoms in the main analyses. As an alternative to this dichotomization and to distinguish between moderate and severe depressive symptoms, we also performed additional analyses where HADS‐D was included as a continuous variable or categorized into 3 groups (\<8, 8--10, ≥11, respectively). The low number of AAAs with high HADS‐D scores made it difficult to define more than 3 categories in our additional analyses, because only 5 of 622 AAA individuals had a HADS‐D score ≥15. The HADS anxiety score (HADS‐A) was not taken into consideration.

Assessment of Other Risk Factors {#jah34504-sec-0015}
--------------------------------

Results from clinical examinations and questionnaires provided data on other potential risk factors. The average of the second and third measurements of systolic and diastolic blood pressure was calculated. Hypertension (yes, no) was defined as systolic blood pressure \>140 mm Hg or diastolic blood pressure \>90 mm Hg or use of antihypertensive medication (self‐reported). Height and weight were measured by the HUNT study. Body mass index (BMI) was computed as weight/height^2^ (kg/m^2^), and divided into 4 categories (\<25, 25--30, 30--35, and ≥35 kg/m^2^). Coronary heart disease (CHD, yes, no) was defined as a composite variable of self‐reported history of myocardial infarction or angina pectoris. Diabetes mellitus (yes, no) and smoking status (never, past, current) were defined according to questionnaire responses (self‐reported). Blood samples were nonfasting, and serum was separated at the screening site and immediately placed in a refrigerator (−48°C). Serum total cholesterol was measured at a single laboratory (Levanger Hospital) as previously described.[25](#jah34504-bib-0025){ref-type="ref"}, [26](#jah34504-bib-0026){ref-type="ref"}

Statistical Analyses {#jah34504-sec-0016}
--------------------

Descriptive statistics at start of follow‐up are presented as mean (SD), median (interquartile range), or as frequencies. The groups defined by HADS‐D (\<8, ≥8) were compared by differences in mean values (95% CI) for continuous variables, and differences in proportions (95% CI) for categorical variables. The univariate Kaplan--Meier method was used to estimate proportions of disease‐free individuals at any point in time (ages) during the follow‐up period, and the log‐rank test was used to compare the 2 groups defined by HADS‐D (\<8 versus ≥8). The number of individuals at risk of AAA at different ages is presented in the Kaplan--Meier plot.

Hazard ratios (HR) with 95% CI for incident AAA were calculated as estimates of relative risk in a multiple Cox proportional hazard regression model. Attained age was used as a time scale. Adjustments were made for sex, total cholesterol, BMI, and smoking, as well as indicator variables (yes, no) for CHD, diabetes mellitus, and hypertension. A variable representing age at measured HADS‐D (\<50, 50--59, 60--69, 70--79, and ≥80 years) was also adjusted for in the regression model. Cholesterol was included in the model as a continuous variable (single term for linear trend), whereas the other continuous variables (age at HADS‐D measurement, BMI) were categorized to allow for a nonlinear association. All risk factors, except sex, were treated as time‐dependent covariates to allow for a shift in the exposure category for individuals who participated in HUNT more than once (the most recent measure that was used during follow‐up defined the risk factor level). The indicator variable for depressive symptoms was defined in terms of exposure at any time (HADS‐D ≥8), but was not updated if the second measurement was \<8 (defined as never, ever).

Additional analyses were performed to explore a potential linear trend (HADS‐D as a continuous variable) or heterogeneity in risk of AAA according to increasing severity of depressive symptoms (HADS‐D \<8, 8--10, ≥11). To distinguish between intermittent and persistent depressive symptoms, a variable based on the HADS‐D scores in both surveys was constructed and divided into never (\<8 at both), intermittent (≥8 at first or second), or persistent (≥8 at both) depressive symptoms. Because of a low number of AAA cases among those with 2 HUNT participations and a HADS‐D score ≥8 (at 1 or both occasions), only age was adjusted for in the analysis of this variable (20 366 individuals were included).

The Cox regression analyses included individuals with complete information on all covariates. To test for heterogeneity regarding association with HADS‐D across subgroups, interaction terms between HADS‐D and each adjustment factor were included in the model, 1 at a time. The proportional hazard assumption was evaluated using log‐minus‐log plots. For adjustment factors that showed deviation from the proportional hazard assumption (smoking status, diabetes mellitus), additional analyses stratified by each of these factors were performed to evaluate whether and to what extent this affected the HR of HADS‐D. All statistical analyses were performed using Stata (Version IC.15.1 Stata Corp, College Station, TX). A *P*\<0.05 was considered statistically significant (2‐sided tests).

Missing Values and Sensitivity Analyses {#jah34504-sec-0017}
---------------------------------------

The proportion of missing values was generally low (range 0.1--11.7%, Table [1](#jah34504-tbl-0001){ref-type="table"}, Table [S1](#jah34504-sup-0001){ref-type="supplementary-material"}), but was highest for HADS‐D (11.7%) and smoking (2.5%). Additional analyses identical to the final adjusted Cox regression model was performed based on multiple imputation for missing values (Table [S2](#jah34504-sup-0001){ref-type="supplementary-material"}). Imputation was carried out using chained equations (n=50 data sets), under the assumption of "missing at random" (Table [S1](#jah34504-sup-0001){ref-type="supplementary-material"}). Sensitivity analyses were performed where continuous variables for systolic and diastolic blood pressure, BMI, and age at HADS measurements replaced the categorical variables used in the main model.

###### 

Demographic and Clinical Characteristics at Start of Follow‐Up[a](#jah34504-note-0003){ref-type="fn"}, Total and by HADS‐D

                                                                Total (N=59 136)      HADS‐D \<8 (N=45 817)   HADS‐D ≥8 (N=6401)   Difference (95% CI) HADS‐D ≥8 vs \<8[b](#jah34504-note-0004){ref-type="fn"}
  ------------------------------------------------------------- --------------------- ----------------------- -------------------- -----------------------------------------------------------------------------
  Age (y) at measured HADS‐D, mean (SD)                         52 218 (56.8 (13.3)                                                4.00 (3.70, 4.40)
  \<50                                                          21 474 (41.1)         55.5 (12.7)             59.5 (12.5)          
  50--60                                                        12 343 (23.6)         19 536 (42.6)           1938 (30.3)          
  60--70                                                        9113 (17.5)           10 786 (23.5)           1557 (24.3)          
  70--80                                                        6931 (13.3)           7860 (17.2)             1253 (19.6)          
  ≥80                                                           2357 (4.5)            5775 (12.6)             1156 (18.0)          
  Missing                                                       6918 (11.7)           1860 (4.1)              497 (7.8)            
  Sex                                                                                                                              
  Women                                                         30 982 (52.4)         24 044 (52.5)           3291 (51.4)          −0.01 (−0.02, 0.002)
  Men                                                           28 154 (47.6)         21 773 (47.5)           3110 (48.6)          
  Smoking                                                                                                                          
  Never                                                         22 639 (32.28)        17 703 (39.3)           2144 (34.1)          −0.05 (−0.06, −0.04)
  Past                                                          18 224 (30.82)        14 352 (31.8)           2004 (31.9)          0.0007 (−0.01, 0.01)
  Current                                                       16 913 (28.60)        13 024 (28.9)           2132 (34.0)          0.05 (0.04, 0.06)
  Missing                                                       1360 (2.3)                                                         
  BMI (kg/m^2^), mean (SD)                                      26.9 (4.1)                                                         0.40 (0.24, 0.45)
  \<25                                                          19 923 (33.69)        26.8 (4.0)              27.1 (4.4)           
  25--29                                                        26 926 (45.53)        15 775 (34.7)           2063 (32.9)          
  30--35                                                        9171 (15.51)          21 118 (46.4)           2794 (44.6)          
  ≥35                                                           2429 (4.11)           6872 (15.1)             1070 (17.0)          
  Missing                                                       687 (1.16)            1731 (3.8)              343 (5.5)            
  CHD                                                                                                                              
  Yes                                                           4841 (8.19)           3135 (6.9)              787 (12.3)           0.05 (0.05, 0.06)
  No                                                            54 (91.71)            42 660 (93.1)           5607 (87.7)          
  Missing                                                       61 (0.10)                                                          
  Diabetes mellitus                                                                                                                
  Yes                                                           2396 (4.1)            157 (3.5)               340 (5.3)            0.020 (0.013, 0.024)
  No                                                            56 593 (95.9)         1589 (96.5)             6032 (94.7)          
  Missing                                                       147 (0.25)                                                         
  Blood pressure (mm Hg)                                                                                                           
  Diastolic, mean (SD)                                          81.2 (12.3)           81.2 (12.1)             81.6 (12.5)          0.44 (0.13, 0.77)
  Systolic, mean (SD)                                           139.5 (12.3)          138.6 (21.6)            140.3 (22.7)         1.74 (1.17, 2.31)
  Combined variable ([c](#jah34504-note-0005){ref-type="fn"})                                                                      
  Hypertension                                                  29 847 (50.47)                                                     0.05 (0.04, 0.07)
  Not hypertension                                              29 249 (49.46)        22 425 (49.0)           3481 (54.4)          
  Missing                                                       40 (0.07)             23 388 (51.0)           2913 (45.6)          
  Cholesterol (mmol/L)                                                                                                             
  Mean (SD)                                                     6.1 (1.2)             6.04(1.2)               6.15 (1.2)           0.10 (0.07, 0.14)
  Missing                                                       1047 (1.8)                                                         

BMI indicates body mass index (kg/m^2^); CHD, coronary heart disease;HADS‐D, Hospital Anxiety and Depression Scale--Depression.

Median age at start of follow‐up was 53.7 years (range 50--101.4).

Differences are given in proportion or mean values with 95% CIs (missing values excluded).

Combined variable of systolic blood pressure \>140 mm Hg or diastolic blood pressure \>90 mm Hg or reported use of antihypertensive medication.

Ethics {#jah34504-sec-0018}
------

The HUNT Study board of directors and the Regional Ethics Committee (2014/175/REK Midt‐Norge) approved this study. The present study was conducted in accordance with the Helsinki Declaration. Every participant included in the HUNT study provided written informed consent. The HUNT databank has precise information on all data exported to different projects and is able to reproduce these on request. Requests to access the data set from qualified researchers may be directed to the HUNT study.[24](#jah34504-bib-0024){ref-type="ref"}

Results {#jah34504-sec-0019}
=======

Characteristics of the Study Population {#jah34504-sec-0020}
---------------------------------------

Table [1](#jah34504-tbl-0001){ref-type="table"} shows characteristics of the study population at start of follow‐up, total, and by HADS‐D. In total, 22 432 of the individuals in the present study participated in HUNT2 only (38%), 4898 in HUNT3 only (8%), whereas 31 806 participated in both surveys (54%) (Figure [1](#jah34504-fig-0001){ref-type="fig"}). The median HADS‐D score among the 52 218 individuals who responded to the questionnaire was 3.0 (interquartile range 1.0--6.9). In all, 12.3% of the study population reported depressive symptoms (HADS‐D ≥8) (men, 12.5% versus women, 12.0%, *P*=0.11). A HADS‐D score ≥8 was associated with several known risk factors for AAA. People with HADS‐D ≥8 were older than those with HADS‐D \<8 (median 57.8 years \[interquartile range 50.0--65.0\] versus 52.3 years \[interquartile range 50.0--70.4\] years, *P*\<0.001), and a statistically significantly higher (*P*\<0.001) proportion of them were smokers (34.0% versus 28.9%), overweight or obese (32.5% versus 18.9%), had higher mean cholesterol levels (6.15 \[95% CI, 6.12--6.18\]) versus 6.04 \[95% CI, 6.03--6.05\]), and reported a history of CHD (12.3% versus 6.9%), diabetes mellitus (5.3% versus 3.5%), and hypertension (54.4% versus 49.0%).

Depressive Symptoms and Risk of AAA {#jah34504-sec-0021}
-----------------------------------

The crude annual incidence rate of AAA was 1.0 per 1000 person‐years, and higher for men than women (1.59 versus 0.49 per 1000). Figure [2](#jah34504-fig-0002){ref-type="fig"} shows the results from the univariate Kaplan--Meier analysis of the association between HADS‐D (missing values excluded) and AAA. At all ages and in both groups defined by HADS‐D, the estimated proportion of individuals diagnosed with AAA was low (\<10%), albeit significantly higher in the group of individuals with HADS‐D ≥8 (*P*\<0.001, log‐rank test). At the age of 60, 70, 80, and 90 years, the difference in estimated proportions with AAA was 0.2% (HADS‐D ≥8) versus 0.1% (HADS‐D\<8), 1.3% versus 0.7%, 4.2% versus 2.7%, and 7.8% versus 5.7%, respectively. Among the individuals diagnosed with AAA, the median time from completion of the HADS‐D questionnaire (HUNT participation) to the date of AAA diagnosis was 10.5 years (range 0.3--18.6 years), and similar between those with and without depressive symptoms. Mean age at diagnosis of AAA was 76.1 years (50.5--100.3 years), and women were 2 years older than men when diagnosed (77.6 versus 75.6 years, *P*=0.005).

![The Kaplan--Meier curve of incident AAAs and numbers at risk during follow‐up according to HADS‐D \<8 vs ≥8. Numbers at risk of AAA are shown among individuals with no missing values for HADS‐D during follow‐up. AAA indicates abdominal aortic aneurysm; HADS‐D, Hospital Anxiety and Depression Scale--Depression.](JAH3-8-e012535-g002){#jah34504-fig-0002}

In a univariable Cox regression analysis (Table [2](#jah34504-tbl-0002){ref-type="table"}), individuals with HADS‐D ≥8 had a 46% higher hazard of incident AAA than those with HADS‐D \<8 (HR, 1.46; 95% CI 1.2--1.8). Adjusted for sex, age at measurement, and known factors associated with AAA (smoking, hypertension, cholesterol levels, BMI, CHD, and diabetes mellitus), individuals with HADS‐D ≥8 had a 31% higher hazard of AAA than those with HADS\<8 (HR, 1.32, 95% CI 1.08--1.61). Current smoking was associated with a considerable increase in risk of AAA (HR 8.72, 95% CI 6.55--11.61). The proportion of smokers was higher among those with depressive symptoms, but introduction of smoking as the last factor in the adjusted model only moderately reduced the HR for HADS‐D (from HR 1.41 to HR 1.32). Incident AAA was \>2.5 times more likely to occur in men than women (HR, 2.64, 95% CI 2.18--3.20). Significant associations were also observed for hypertension, CHD, and increasing cholesterol levels, while a borderline protective effect was found for diabetes mellitus in the fully adjusted model. No significant association was found with BMI. Additional analyses with smoking status and diabetes mellitus as stratification variables because of deviation from proportional hazard assumption did not change the risk estimates for HADS‐D notably.

###### 

HR with 95% CI for the Association Between HADS‐D and AAA Development[a](#jah34504-note-0007){ref-type="fn"}

                           No. of AAA n   Univariable HR (95% CI)   Multivariable HR (95% CI)[b](#jah34504-note-0008){ref-type="fn"}
  ------------------------ -------------- ------------------------- ------------------------------------------------------------------
  HADS‐D                                                            
  \<8                      513            1.00                      1.0
  ≥8                       109            1.46 (1.19--1.78)         1.32 (1.08--1.61)
  *P* value                               \<0.001                   0.007
  Sex                                                               
  Women                    161            1.00                      1.00
  Men                      461            3.51 (2.93--4.20)         2.64 (2.18--3.20)
  *P* value                               \<0.001                   \<0.001
  Smoking                                                           
  Never                    61             1.00                      1.00
  Past                     204            4.78 (3.60--6.35)         3.17 (2.36--4.25)
  Current                  357            11.20 (8.47--14.80)       8.72 (6.56--11.61)
  *P* value                               \<0.001                   \<0.001
  CHD                                                               
  No                       460            1.00                      1.00
  Yes                      162            2.83 (2.383.37)           2.39 (2.00--2.85)
  *P* value                               \<0.001                   \<0.001
  Diabetes mellitus                                                 
  No                       601            1.00                      1.00
  Yes                      21             0.81 (0.57--1.15)         0.75 (0.52--1.08)
  *P* value                               0.25                      \<0.12
  Hypertension                                                      
  No                       174            1.00                      1.00
  Yes                      448            1.25 (1.04--1.51)         1.35 (1.12--1.62)
  *P* value                               0.016                     0.002
  BMI, m/kg^2^                                                      
  \<25                     196            1.00                      1.00
  25--29                   305            0.88 (0.74--1.06          0.96 (0.80--1.16)
  30--34                   103            0.84 (0.67--1.06          1.10 (0.87--1.41)
  ≥35                      18             0.71 (0.46--1.08)         1.19 (0.77--1.84)
  *P* value                               0.25                      0.56
  Cholesterol (mmol/L)     622            0.97 (0.91--1.03)         1.10 (1.03--1.17)
  *P* value                               0.39                      0.005
  Age (y) at measurement                                            
  \<50                     38             1.89 (0.98--3.65)         1.43 (0.75--2.75)
  50--59                   128            1.16 (0.77--1.77)         0.98 (0.65--1.49)
  60--69                   248            1.00                      1.00
  70--79                   185            1.26 (0.99--1.60)         1.17 (0.92--1.48)
  ≥80                      23             0.69 (0.48--0.98)         0.74 (0.52--1.06)
  *P* value                               0.02                      0.13

Number of individuals, n=50 657 (622 AAA). AAA, indicates abdominal aortic aneurysm; BMI, body mass index (kg/m^2^); CHD, coronary heart disease; HADS‐D, Hospital Anxiety and Depression Scale--Depression; HR, hazard ratios.

HR estimates with 95% CIs calculated in a Cox proportional hazard regression model with attained age as time scale.

Adjusted for age at HADS‐D measure (HUNT participation), sex, diabetes mellitus, BMI category, coronary heart disease, hypertension, total cholesterol, and smoking.

Table [3](#jah34504-tbl-0003){ref-type="table"} presents HRs for AAA in relation to HADS‐D measured as a continuous variable, as an ordinal categorical variable (\<8, 8--11, ≥11), and with combined data from HUNT2 and HUNT3 (never, intermittent, persistent). A significant linear trend was observed between increasing HADS‐D and risk of AAA in the unadjusted analysis, but not in the adjusted analyses. Moreover, individuals with severe depressive symptoms (HADS‐D ≥11) did not have higher risk of AAA than individuals with less severe (HADS‐D 8--10) symptoms (HR of 1.02 versus 1.42, compared with HADS‐D \<8) (Figure [3](#jah34504-fig-0003){ref-type="fig"}). The number of individuals with AAA and a HADS‐D ≥11 was low (n=29). Among individuals with valid HADS‐D in both HUNT2 and HUNT3 (n=20 366), 82% reported no depressive symptoms (HADS‐D \<8 at both surveys), 13% intermittent symptoms (HADS‐D ≥8 at only 1 survey), and 4.2% persistent symptoms (HADS‐D≥8 at both surveys). Those with persistent symptoms did not have significantly higher risk of AAA than those with intermittent symptoms, but both had higher risk compared with individuals with no depressive symptoms (HR, 1.50 and 1.41, respectively).

###### 

HR With 95% CI for the Association Between HADS‐D (Continuous, 3 Categories, Combined Values from HUNT2 and HUNT3), and Risk of AAA[a](#jah34504-note-0010){ref-type="fn"}

  Factors                                                    No. of AAA n   Univariable HR (95% CI)   Multivariable HR (95% and CI)[b](#jah34504-note-0011){ref-type="fn"}
  ---------------------------------------------------------- -------------- ------------------------- ----------------------------------------------------------------------
  HADS‐D, continuous (0--21)                                 622            1.03 (1.01--1.06)         1.02 (0.99--1.04)
  *P* for trend                                                             0.007                     0.16
  HADS‐D (3 categories)                                                                               
  \<8                                                        513            1.00                      1.00
  8--10                                                      80             1.55 (1.24--1.94)         1.43 (1.15--1.79)
  ≥11                                                        29             1.21 (0.81--1.79)         1.03 (0.70--1.53)
  *P* for trend                                                             0.0005                    0.007
  HADS‐D (combined)[c](#jah34504-note-0012){ref-type="fn"}                                            
  Never                                                      120            1.00                      ...
  Intermittent                                               31             1.41 (0.95--2.1)          
  Persistent                                                 11             1.50 (0.81--2.8)          
  *P* for trend                                                             0.13                      

Number of individuals (continuous vs 3 categories), n=50 657. Number of individuals (combined categories), n=20 366. AAA, abdominal aortic aneurysm; HADS‐D, Hospital Anxiety and Depression Scale--Depression; HR, hazard ratios; HUNT, Norwegian Nord‐Trøndelag Health Study.

HR estimates with 95% CIs calculated in a Cox proportional hazard regression model with attained age as time scale.

HR estimates with 95% CI for all 3 HADS‐D variables (continuous vs 3 categories, combined categories) in separate models, but equally adjusted for age at HADS‐D measure (HUNT participation), sex, diabetes mellitus, body mass index, coronary heart disease, hypertension, total cholesterol, and smoking.

Combined categories of HADS‐D were defined as, never (\<8, \<8), intermittent (\<8,≥8 or ≥8,\<8), persistent (≥8, ≥8).

![HR with 95% CI for association between HADS‐D (3 categories, with \<8 as reference group) and risk of AAA. HR for dichotomized HADS‐D (≥8 vs \<8) and HR for linear trend (per unit increase) are also shown. HR values were calculated in a Cox proportional hazard regression model with attained age as time scale, adjusted for age at HADS‐D measure (HUNT participation), sex, diabetes mellitus, body mass index category, coronary heart disease, hypertension, total cholesterol, and smoking category. AAA indicates abdominal aortic aneurysm; HR, hazard ratio; HUNT, Norwegian Nord‐Trøndelag Health Study; HUNT, Norwegian Nord‐Trøndelag Health Study.](JAH3-8-e012535-g003){#jah34504-fig-0003}

Subgroup Analyses {#jah34504-sec-0022}
-----------------

The results from the analyses of the association between HADS‐D and AAA analyzed in subgroups of each of the included covariates are presented in Table [4](#jah34504-tbl-0004){ref-type="table"}. The proportion with AAA was \<10% in all age groups, and the numbers of AAAs in some subgroups were low. The risk estimates were therefore imprecise, and neither of the interaction terms reached statistical significance or added information to the main model (range, *P* interaction: 0.22--0.61), partly because of low power of the test. This limits the generalizability of the results from the subgroup analyses. In our study, however, the association between depressive symptoms and AAA was slightly more pronounced in women than men (HR of 1.56 versus 1.24), and among those with high cholesterol and reported hypertension. In contrast, the association between depressive symptoms and AAA was somewhat lower in subgroups of smokers, and among people with lower BMI, reported CHD, and diabetes mellitus.

###### 

Subgroup Analysis and Tests for Interactions: HR with 95% CI for Incident AAA in People With Versus Without Depressive Symptoms, in Subgroups Defined by Other Risk Factors[a](#jah34504-note-0014){ref-type="fn"}

                              No. of AAA   HR (95% CI)   
  --------------------------- ------------ ------------- --------------------------------------------------------
  Sex                                                    
  Men                         384          32            1.24 (0.9--1.6)
  Women                       129          77            1.56 (1.1--2.3)
  Age at measured HADS‐D, y                              
  \<60                        131          35            1.88 (1.2--3.0)
  60--70                      211          37            1.35 (0.9--1.9)
  70--80                      153          32            1.15 (0.9--1.5)[b](#jah34504-note-0015){ref-type="fn"}
  ≥80                         18           5             
  CHD                                                    
  Yes                         131          31            1.17 (0.8--1.7)
  No                          382          78            1.40 (1.1--1.8)
  Diabetes mellitus                                      
  Yes                         17           4             0.90 (0.4--2.2)
  No                          496          105           1.35 (1.1--1.7)
  Hypertension                                           
  Yes                         372          76            1.3 (1.1--1.6)
  No                          141          33            1.13 (0.7--1.7)
  Smoking                                                
  Never                       50           11            1.67 (0.9--3.1)
  Past                        170          34            1.40 (1.0--1.9)
  Current                     293          64            1.22 (0.9--1.6)
  BMI                                                    
  \<25                        158          38            1.54 (1.1--2.2)
  25--29                      251          54            1.28 (0.9--1.7)
  30--35                      91           12            1.11 (0.7--1.7)[b](#jah34504-note-0015){ref-type="fn"}
  ≥35                         13           5             
  Cholesterol, mmol/L                                    
  \<6.5                       284          56            1.16 (0.9--1.6)
  ≥6.5                        221          61            1.51 (1.1--2.0)

AAA indicates abdominal aortic aneurysm; BMI, body mass index; CHD, coronary heart disease; HADS‐D, Hospital Anxiety and Depression Scale--Depression; HR, hazard ratio.

Results based on Cox proportional hazard regression model adjusted for all factors, and with interaction terms (dichotomized score and each risk factor) included 1 at a time.

Last 2 categories combined. *P* for interaction, range: 0.22 to 0.61. Cholesterol dichotomized at 6.5 mmol/L, based on clinically used values.

Sensitivity Analyses {#jah34504-sec-0023}
--------------------

In the sensitivity analyses where systolic and diastolic blood pressure, respectively, replaced the dichotomized hypertension variable based on combined values, the HR for HADS‐D did not change notably (systolic blood pressure: HR=1.32 \[1.1--1.6\], diastolic blood pressure: HR=1.33 \[1.1--1.6\]). Only diastolic blood pressure was significantly associated with AAA (HR, diastolic blood pressure=1.02 \[1.01--1.02\]). In a sensitivity analysis where all the categorized variables were treated as continuous variables (BMI, systolic or diastolic blood pressure), the HR for HADS‐D remained unchanged (HR=1.32 \[1.1--1.6\]). Analyses based on data with multiple imputation for missing values (n=59 136, n=742 AAA) produced results similar to those based on complete cases (Table [S2](#jah34504-sup-0001){ref-type="supplementary-material"}). An unadjusted HR for the association between HADS‐D≥8 and AAA was 1.45 (95% CI, 1.2--1.8, *P*\<0.001) after multiple imputation, whereas the multivariate adjusted HR was 1.30 (95% CI, 1.07--1.59, *P*=0.009).

Discussion {#jah34504-sec-0024}
==========

In this large, prospective population‐based study, individuals with symptoms of depression had ≈30% higher risk of incident AAA than individuals without depressive symptoms. The association remained significant after adjustment for established risk factors for AAA, and the importance of smoking, male sex, CHD, hypertension, and increasing levels of cholesterol was confirmed.

An association between depressive symptoms and risk of AAA has only been reported in 1 previous study. In a population‐based study evaluating 12 different disease outcomes, depression was associated with subsequent cardiac, cerebrovascular, and peripheral arterial disease, as well as AAA.[12](#jah34504-bib-0012){ref-type="ref"} However, the follow‐up time in the present study was more than twice as long, and the association between depressive symptoms and AAA was stronger than the previously reported 12% increase in risk. The lower risk may be related to a different assessment of depressive symptoms (diagnosed by general practitioner).

Although the risk of AAA was higher among individuals with depressive symptoms defined by a HADS‐D ≥8, no difference was found between individuals with severe (HADS‐D ≥11) and less severe symptoms (HADS‐D 8--11). The number of individuals with severe depressive symptoms was low in our study population, which might result from recruitment bias. Individuals with depression, particularly severe depression, tend to not attend screening programs or population‐based studies upon invitation.[29](#jah34504-bib-0029){ref-type="ref"}, [30](#jah34504-bib-0030){ref-type="ref"}, [31](#jah34504-bib-0031){ref-type="ref"} Only 5 of 622 AAA individuals had a HADS‐D score ≥15. It is possible that this may have led to an underestimation of the association between depressive symptoms and AAA (selection bias). Moreover, we found no marked difference between the effect of intermittent and persistent symptoms of depression in the subgroup with repeated measurements of HADS‐D, but the results from these analyses were imprecise.

Depression is associated with several negative behavioral factors such as smoking, lower rate of smoking cessation,[32](#jah34504-bib-0032){ref-type="ref"} alcohol and drug abuse, less physical activity, poor diet, impaired self‐care, and low adherence to prescribed drugs.[33](#jah34504-bib-0033){ref-type="ref"}, [34](#jah34504-bib-0034){ref-type="ref"} Indisputably, smoking is the major risk factor for AAA,[4](#jah34504-bib-0004){ref-type="ref"}, [5](#jah34504-bib-0005){ref-type="ref"}, [35](#jah34504-bib-0035){ref-type="ref"}, [36](#jah34504-bib-0036){ref-type="ref"}, [37](#jah34504-bib-0037){ref-type="ref"} which our data also support. Otherwise, there have been no consistently reported associations between these factors and risk of AAA. A recent study reported a reduced risk of AAA among individuals who walked or bicycled \>40/min per day.[36](#jah34504-bib-0036){ref-type="ref"} Another study reported lower risk of AAA among individuals adhering to a diet aiming to prevent hypertension.[38](#jah34504-bib-0038){ref-type="ref"} Although we did not adjust for these 2 factors, the adjustments made for BMI, diabetes mellitus, and cholesterol levels may indirectly reflect the effect of physical activity and diet. Thus, it is unlikely that any of the abovementioned factors would lead to severe bias in the risk estimates for HADS‐D because of confounding. There are other lifestyle factors that may also be considered to influence the risk of AAA, such as lower level of education[39](#jah34504-bib-0039){ref-type="ref"}, [40](#jah34504-bib-0040){ref-type="ref"}, [41](#jah34504-bib-0041){ref-type="ref"} and low socioeconomic status.[42](#jah34504-bib-0042){ref-type="ref"}, [43](#jah34504-bib-0043){ref-type="ref"}, [44](#jah34504-bib-0044){ref-type="ref"}, [45](#jah34504-bib-0045){ref-type="ref"} We did not have these data in the present study, and cannot exclude that this may have resulted in an overestimation of the association between depressive symptoms and AAA. On the other hand, depressive symptoms were not considered as an explanatory factor in the previous studies. In summary, apart from family history, the present study has performed multivariable adjustments for all other established risk factors for AAA.

Some studies suggest that the elevated risk of CVD among individuals with depression is more pronounced among women than men,[46](#jah34504-bib-0046){ref-type="ref"} although the results are inconsistent.[10](#jah34504-bib-0010){ref-type="ref"}, [13](#jah34504-bib-0013){ref-type="ref"}, [47](#jah34504-bib-0047){ref-type="ref"} There was no significant difference in the association between depression and AAA in women compared with men, although the relative risk estimates were slightly higher for women. The lack of statistical significance may be because of low power in the interaction tests. The study by Daskalopoulou et al reported somewhat similar risk estimates for both men and women (HR, men 1.15 versus HR, women 1.09).[12](#jah34504-bib-0012){ref-type="ref"}

The risk of depression has been reported to be higher among those with established CVD,[48](#jah34504-bib-0048){ref-type="ref"}, [49](#jah34504-bib-0049){ref-type="ref"} but depression is also a risk factor for development of CVD,[10](#jah34504-bib-0010){ref-type="ref"}, [11](#jah34504-bib-0011){ref-type="ref"}, [13](#jah34504-bib-0013){ref-type="ref"}, [47](#jah34504-bib-0047){ref-type="ref"} indicating a bidirectional effect. These observations are based on contributions from different studies. A similar bidirectional relationship between depression and AAA has not yet been established. Depression has been found to be more prevalent among patients diagnosed with AAA than in the general population.[50](#jah34504-bib-0050){ref-type="ref"}, [51](#jah34504-bib-0051){ref-type="ref"} To our knowledge, only 1 previous study has shown that depression might be a risk factor for AAA.[12](#jah34504-bib-0012){ref-type="ref"} Thus, our study adds evidence supporting that a bidirectional relationship may also exist between depression and AAA.

Strengths and Limitations {#jah34504-sec-0025}
-------------------------

Our study has some major strengths. The prospective design, the size of the study population, and the duration of follow‐up made it possible to address the association between depression and the risk of AAA, adjusted for a comprehensive range of potential confounding factors. The access to repeated measurements of risk factors made it possible to account for changes in the exposure levels during follow‐up (defined as time‐varying covariates). The numbers at risk within a particular risk group are then more correctly defined, thereby reducing potential bias in the risk estimates because of misclassification of the exposure variable. All diagnoses of AAA were *ICD*‐based and verified manually from patient charts. The association with HADS‐D was consistently observed across subgroups, although the magnitude of risk estimates varied somewhat. The results based on the analyses that used sets of imputed values for missing values were nearly identical to the results from complete case analyses.

However, there are also some limitations that should be addressed. The evaluation of depression and other risk factors was largely based on self‐reported questionnaires, potentially leading to information bias.[28](#jah34504-bib-0028){ref-type="ref"}, [52](#jah34504-bib-0052){ref-type="ref"} Symptoms of depression may vary over time, and we did not have repeated measures on all individuals in our cohort. Thus, potential misclassification might have occurred, despite the use of time‐dependent covariates. However, possible misclassification is likely to have been random, most probably resulting in an underestimation of relative risk estimates. There was no information about use of antidepressants, family history of AAA or physical activity, and unmeasured unknown confounding is always a limitation. The amount of missing data was highest for HADS‐D, particularly among the oldest age groups, for which reason the occurrence of depression may potentially have been underestimated. Moreover, it is likely that asymptomatic AAA was underdiagnosed. The observed 1.2% occurrence of incident AAA in our study was consistent with the expected rate,[53](#jah34504-bib-0053){ref-type="ref"} even though it was based on identification of diagnosed AAA, since ultrasound examination of the abdominal aorta was not part of the HUNT study.

Implications {#jah34504-sec-0026}
------------

Our study provides significant new support to include assessment of depression in the evaluation of risk of AAA, which could potentially be especially important when screening subgroups at increased risk of this disease.

Conclusions {#jah34504-sec-0027}
===========

Depression has previously been linked to the risk of CHD and stroke. In this large population‐based, prospective study, individuals with symptoms of depression had significantly higher risk of AAA, even after adjustment for established risk factors.
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